Home > Insider Trading > Filing (0001127602-16-048902)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
64803	Cvs Health Corp	CVS	Retail-Drug Stores And Proprietary Stores (5912)	050494040

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1515706	Andrew Sussman	One Cvs Drive Woonsocket RI 02895	Evp & Pres, Cvs Minuteclinic	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2016-04-01	2,844	$105.00	11,041	No	4	S	Direct
Common Stock	Disposition	2016-04-01	1,319	$104.82	12,473	No	4	F	Direct
Common Stock (Restricted)	Acquisiton	2016-04-01	3,100	$104.82	17,313	No	4	A	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	F	Direct
No	4	A	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option	Acquisiton	2016-04-01	23,301	$104.82	23,301	$104.82

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
23,301	2017-04-01	2023-04-01	No	4	A	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Stock Unit	8,115	Direct

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Stock Option	$45.07	2012-04-02	2019-04-02	6,655	6,655	Direct
Common Stock	Stock Option	$36.96	2012-09-01	2019-09-01	0	0	Direct
Common Stock	Stock Option	$54.53	2014-04-01	2020-04-01	11,802	11,802	Direct
Common Stock	Stock Option	$74.29	2015-04-01	2021-04-01	29,373	29,373	Direct
Common Stock	Stock Option	$102.26	2016-04-01	2022-04-01	23,968	23,968	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2019-04-02	6,655	6,655	Direct
2019-09-01	0	0	Direct
2020-04-01	11,802	11,802	Direct
2021-04-01	29,373	29,373	Direct
2022-04-01	23,968	23,968	Direct

Footnotes

Sales were effected pursuant to a Rule 10b5-1 plan.
Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock unit award.
Consists of restricted stock units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/1/2019 and 50% on 4/1/2021.
Option becomes exercisable in four equal annual installments, commencing 4/1/2017.
Option became exercisable in four equal annual installments, commencing 4/2/2013.
Option became exercisable in three equal annual installments, commencing 9/1/2012.
Option became exercisable in four equal annual installments, commencing 4/1/2014.
Option became exercisable in four equal annual installments, commencing 4/1/2015.
Option became exercisable in four equal annual installments, commencing 4/1/2016.